Market Cap (In USD)
185.39 Thousand
Revenue (In USD)
149.52 Thousand
Net Income (In USD)
-210.11 Thousand
Avg. Volume
2.53 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.0E-4-6.0E-4
- PE
- -
- EPS
- -
- Beta Value
- 2.028
- ISIN
- US3685331056
- CUSIP
- 368533105
- CIK
- 890725
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Javier G. Acosta
- Employee Count
- -
- Website
- https://www.gelstat.com
- Ipo Date
- 1996-02-09
- Details
- GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.
More Stocks
-
3526
-
CACarrefour SA
CA
-
KNDI
-
BIRLACABLEBirla Cable Limited
BIRLACABLE
-
MBISFOrange Belgium S.A.
MBISF
-
LIMAFLinamar Corporation
LIMAF
-
WESTLIFEWestlife Foodworld Limited
WESTLIFE
-
DTSRF